1858 Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$467K Sell
4,783
-1,099
-19% -$114K 0.33% 58
2025
Q2
$632K Sell
5,882
-265
-4% -$26.8K 0.47% 46
2025
Q1
$620K Buy
6,147
+204
+3% +$20.5K 0.53% 49
2024
Q4
$531K Buy
5,943
+3,051
+105% +$269K 0.42% 62
2024
Q3
$242K Sell
2,892
-59
-2% -$4.65K 0.2% 98
2024
Q2
$227K Buy
+2,951
New +$216K 0.19% 104

Other funds holding BSX

1858 Wealth Management's BSX Position: Q3 2025 in Review

1858 Wealth Management reduced its Boston Scientific (BSX) stake by 19% in Q3 2025, selling an estimated $114K and leaving 4,783 shares worth $467K. The position accounts for 0.33% of the portfolio, ranked #58.

1858 Wealth Management first reported a position in BSX in Q2 2024 and has held it in 6 quarters since. The position peaked at $632K in Q2 2025. 1,709 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • 1858 Wealth Management held 4,783 shares of Boston Scientific worth $467K as of Q3 2025.
  • 1858 Wealth Management sold 1,099 Boston Scientific shares in Q3 2025, an estimated $114K.
  • Boston Scientific made up 0.33% of 1858 Wealth Management's portfolio in Q3 2025, its #58 holding.
  • 1858 Wealth Management first reported a position in Boston Scientific in Q2 2024 and has held it in 6 quarters since.
  • 1858 Wealth Management's Boston Scientific position peaked at $632K in Q2 2025.
  • 1,709 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on 1858 Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.